-
P-selectin
- Sialyl-Lewis X-modified proteins
- roles--rolling
-
E-selectin
- Sialyl-Lewis X-modified proteins
- roles--rolling and adhesion
-
GlyCam-1, CD34
- L-selectin
- roles: Rolling (neutrophils, monocytes)
-
ICAM-1 (immunoglobulin family)
- CD11/CD18 integrins (LFA-1, Mac-1)
- roles: firm adhesion, arest, transmigration
-
VCAM-1 (immunoglobulin family)
- VLA-4 integrin
- roles: Adhesion
-
CD31
- CD31 (homotypic interaction)
- roles: Transmigration of leukocytes through endothelium.
-
Sources of chemical mediators
- cells (histamine, serotonin, prostglandins, leukotrienes, platelet-activating factor, ROS, NO, cytokines [TNF, IL-1, IL-6], chemokines)
- plasma: synthesized in liver (complement, kinins, and proteases activated during coagulation)
-
Cell-derived mediators
- preformed mediators in secretory granules: histamine, serotonin (from mast cells, basophils, platelets)
- newly synthesized: prostglandins, leukotrienes, platelet-activating factor, ROS, NO, cytokines, neuropeptides (from leukocytes, mast cells, EC, macrophages, lymphocytes, nerve fibers)
-
Plasma protein-derived mediators
- complement activation: C3a and C5a (anaphylatoxins), C3b, C5b-9 (membrane attack complex)
- Factor XII (Hageman factor) activation: Kinin system (bradykinin), coagulation/fibrinolysis ystem
-
Histamine
- From mast cells, basophils, platelets
- vasodilation, increased vascular permeability, endothelial activation
-
Serotonin
- from platelets
- vasoconstriction
-
Prostaglandins
- from mast cells and leukocytes
- vasodilation, pain, and fever
-
leukotrienes
- from mast cells and leukocytes
- increased vascular permeability, chemotaxis, leukocyte adhesion and activation
-
Platelet-activating factor
- from leukocytes and mast cells
- vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst, bronchoconstriction
-
ROS
- from leukocytes
- killing of microbes, tissue damage
-
Nitric Oxide (NO)
- from endothelium and macrophages.
- vascular smooth muscle relaxation, killing of microbes.
-
Cytokines (TNF, IL-1, IL-6)
- from macrophages, endothelial cells, and mast cells
- local: endothelial activation (expression of adhesion molecules). Systemic: fever, metabolic abnormalities, hypotension (shock). They are proteins that modulate the function of other cell types. They bind to specific receptors on target cells.
-
chemokines
- from leukocytes and activated macrophages
- chemotaxis and leukocyte activation
-
complement
- from plasma
- leukocyte chemotaxis and activation, direct target killing (MAC), vasodilation (mast cell stimulation)
-
Kinins
- from plasma
- increased vascular permeability, smooth muscle contraction, vasodilation, pain
-
Two pathways that arachidonic acid undergoes
- Cyclooxygenase pathway
- lipoxygenase pathway
-
Proteases activated during coagulation
- from plasma
- endothelial activation, leukocyte recruitment
-
Cyclooxygenases
prostglandins and thromboxanes
-
Lipoxygenases
leukotrienes and lipoxins
-
Prostaglandins
- Vasodilation
- potentiates inflammation
- inhibits platelets
- pain
- fever
-
Thromboxanes
- vasoconstriction
- platelet aggregation
-
Leukotrienes
- vasoconstriction
- bronchospasm
- increase vascular permeability
-
Lipoxins
- inhibit inflammation
- decrease leukocyte chemotaxis
-
What inhibits Phospholipase A2?
corticosteroids
-
What inhibits cyclooxygenase pathway?
NSAIDS
-
Three interrelated plasma-derived mediators that play a key role in inflammatory response
- complement system
- kinin system
- clotting factor system
-
Complement System
- Assembly of the MAC (membrane attack complex) with lysis of offending agent. Two mechanisms:
- -classical pathway (cytokines and endotoxins...NO and ROS kills ingested organisms, stimulates inflammation)
- -alternate complement pathway (not actively microbicidal, involved in tissue repair, promote angiogenesis, activate fibroblasts, collagen synthesis)
-
-
C3a
- Anaphylatoxin
- mast cell degranulation
- increase in vascular permeability
-
C5a
- Anaphylatoxin
- mast cell degranulation
- increase vascular permeability
- **ACTIVATES ARACHIDONIC ACID PATHWAY
- CHEMOTACTIC FOR LEUKOCYTES
-
Clotting system's two divisions
- Intrinsic pathway-consists of plasma proenzymes which can be activated by Hageman factor, results in activation of thrombin, cleavage of fibrin and generation of fibrin clot
- Extrinsic pathway
-
Chronic Inflammation
- Tissue infiltration by mononuclear cells--macrophages, lymphocytes, plasma cells
- Tissue destruction--induced by products of inflammatory cells
- attempts at repair--CT replacement, angiogenesis, fibrosis
-
Phagocytes in Liver
Kupffer cells
-
Phagocytes in spleen and lymph nodes
sinus histiocytes
-
Phagocytes in CNS/retina
microglial cells
-
Classically activated macrophage (M1)
- ROS, NO, Lysosomal enzymes-->leads to microbicidal actions, phagocytosis and killing of many bacteria and fungi
- IL-1, IL-12, IL-23, and chemokines-->inflammation
-
Alternatively activated macrophage (M2)
- Growth factors, TGF-beta-->Tissue repair and fibrosis
- IL-10 and TGF-beta-->Anti-inflammatory effects
-
Outcome of chronic inflammation
- resolution/regeneration/restitution of normal structure
- repair/organization/healing by CT/fibrosis/scarring
- It can continue indefinitely...i.e. rheumatoid arthritis
-
Diagnostic tests for inflammation
- CRP: C reactive protein
- SAA: Serum amyloid A
- ESR: Erythrocyte Sedimentation rate
- Leukocyte count:neutrophilia, eosinophilia, lymphocytosis, lymphopenia
-
Cachexia
loss of weight, muscle atrophy, fatigue, weakness, and significantloss of appetite in someone who is not actively trying to lose weight. The formal definition of cachexia is the loss of body mass that cannot be reversed nutritionally: Even if the affected patient eats more calories, lean body mass will be lost, indicating a primary pathology is in place.
-
RESTASIS
cyclosporin A emulsion
|
|